Search

Search Constraints

You searched for: Author/Creator Peled, Amnon

Search Results

1. BL‐8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open‐label safety and efficacy phase 2a study. Issue 8 (3rd December 2020)

2. Effects of pharmacological and genetic disruption of CXCR4 chemokine receptor function in B‐cell acute lymphoblastic leukaemia. (12th April 2016)

3. In the Hunt for Therapeutic Targets. Issue 1 (January 2015)

4. In the Hunt for Therapeutic Targets: Mimicking the Growth, Metastasis, and Stromal Associations of Early-Stage Lung Cancer Using a Novel Orthotopic Animal Model. Issue 1 (January 2015)

5. Inflammation‐induced hepatocellular carcinoma is dependent on CCR5 in mice. Issue 3 (12th July 2013)

6. Interleukin 6–dependent genomic instability heralds accelerated carcinogenesis following liver regeneration on a background of chronic hepatitis. Issue 5 (23rd March 2017)

7. Interstrain differences in chronic hepatitis and tumor development in a murine model of inflammation‐mediated hepatocarcinogenesis12. Issue 1 (27th May 2013)